Annals of Oncology

News:

Restructuring English oncology: Will it improve participation in clinical trials and cancer patient care?
Ann Oncol 12: 139.
[PDF] [Request Permissions]

Medical oncology in Europe: More efforts needed
Ann Oncol 12: 139-140.
[PDF] [Request Permissions]

"You've come a long way, baby"
Ann Oncol 12: 140.
[PDF] [Request Permissions]

Nokia, Ericsson and others are happier .........
Ann Oncol 12: 140-141.
[PDF] [Request Permissions]

Murder
Ann Oncol 12: 141.
[PDF] [Request Permissions]

Perhaps not everyone knows that.........
Ann Oncol 12: 141-143.
[PDF] [Request Permissions]

Book reviews:

C. Tondini

Book review
Ann Oncol 12: 144.
[PDF] [Request Permissions]

Editorials:

D. H. Brewster, M. P. Coleman, D. Forman, and M. Roche

Cancer information under threat: The case for legislation
Ann Oncol 12: 145-147.
[PDF] [Request Permissions]

M. R. Gilbert

Neuro-oncology clinical trials: Promise and pitfalls
Ann Oncol 12: 149-150.
[PDF] [Request Permissions]

Reviews:

P. Saletti, I. Dove Edwin, K. Pack, F. Cavalli, and W. S. Atkin

Microsatellite instability: Application in hereditary non-polyposis colorectal cancer
Ann Oncol 12: 151-160.
[Abstract] [PDF] [Request Permissions]

S. A. Hussain, D. R. Ferry, G. El-Gazzaz, D. F. Mirza, N. D. James, P. McMaster, and D. J. Kerr

Hepatocellular carcinoma
Ann Oncol 12: 161-172.
[Abstract] [PDF] [Request Permissions]

Original articles:

S. Franceschi, L. Dal Masco, L. Augustin, E. Negri, M. Parpinel, P. Boyle, D. J. A. Jenkins, and C. La Vecchia

Dietary glycemic load and colorectal cancer risk
Ann Oncol 12: 173-178.
[Abstract] [PDF] [Request Permissions]

C. Garufi, C. Nisticò, A. Vaccaro, A. D'Ottavio, A. R. Zappalà, A. M. Aschelter, and E. Terzoli

Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study
Ann Oncol 12: 179-182.
[Abstract] [PDF] [Request Permissions]

C. Penz, G. V. Kornek, M. Raderer, H. Ulrich-Pur, W. Fiebiger, A. Lenauer, D. Depisch, G. Krauss, B. Schneeweiss, and W. Scheithauer

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
Ann Oncol 12: 183-186.
[Abstract] [PDF] [Request Permissions]

A. Bonetti, M. Zaninelli, R. Leone, T. Franceschi, A. P. Fraccon, F. Pasini, R. Sabbioni, G. L. Cetto, D. Sich, S. Brienza, and S. B. Howell

Use of the ratio of time to progression following first-and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma
Ann Oncol 12: 187-191.
[Abstract] [PDF] [Request Permissions]

A. Kakolyris, D. Mavroudis, N. Tsavaris, J. Souglakos, P. Tsiafaki, K. Kalbakis, S. Agelaki, N. Androulakis, and D. Georgoulias

Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
Ann Oncol 12: 193-198.
[Abstract] [PDF] [Request Permissions]

F. Caponigro, E. Massa, G. Rosati, M. Biglietto, L. De Lucia, C. Sguotti, P. Sganga, A. Avallone, P. Comella, G. Mantovani, and G. Comella

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)
Ann Oncol 12: 199-202.
[Abstract] [PDF] [Request Permissions]

L. Pagano, A. Pulsoni, L. Mele, M. E. Tosti, R. Cerri, G. Visani, L. Melillo, A. Candoni, M. Clavio, A. Nosari, M. C. Petti, B. Martino, A. Mele, A. Levis, B. Allione, C. Almici, F. Equitani, G. Leone, and F. Mandelli

Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group
Ann Oncol 12: 203-207.
[Abstract] [PDF] [Request Permissions]

H. H. J. Backus, D. F. Dukers, C. J. van Groeningen, W. Vos, E. Bloemena, D. Wouters, J. M. G. H. van Reil, K. Smid, G. Giaccone, H. M. Pinedo, and G. J. Peters

5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients
Ann Oncol 12: 209-216.
[Abstract] [PDF] [Request Permissions]

V. Bourg, C. Lebrun, R. M. Chichmanian, P. Thomas, and M. Frenay

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: Increase of haematologic toxicity
Ann Oncol 12: 217-219.
[Abstract] [PDF] [Request Permissions]

B. Hanke, C. Riedel, S. Lampert, K. Happich, P. Martus, H. Parsch, B. Himmler, W. Hohenberger, E. G. Hahn, and A. Wein

CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)
Ann Oncol 12: 221-226.
[Abstract] [PDF] [Request Permissions]

J. Zidan, N. Haim, A. Beny, M. Stein, E. Gez, and A. Kuten

Octreotide in the treatment of severe chemotherapy-induced diarrhea
Ann Oncol 12: 227-229.
[Abstract] [PDF] [Request Permissions]

J. Y. Pierga, M. Robain, M. Jouve, B. Asselain, V. Diéras, P. Beuzeboc, T. Palangié, T. Dorval, J.-M. Extra, S. Scholl, and P. Pouillart

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients
Ann Oncol 12: 231-237.
[Abstract] [PDF] [Request Permissions]

S. Cascinu, F. Graziano, M. Valentini, V. Catalano, P. Giordani, M. P. Staccioli, C. Rossi, A. M. Baldelli, C. Grianti, P. Muretto, and G. Catalano

Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: Relationships with tumor recurrence and resistance to adjuvant chemotherapy
Ann Oncol 12: 239-244.
[Abstract] [PDF] [Request Permissions]

P. J. Mulholland, D. R. Ferry, D. Anderson, S. A. Hussain, A. M. Young, J. E. Cook, E. Hodgkin, L. W. Seymour, and D. J. Kerr

Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin
Ann Oncol 12: 245-248.
[Abstract] [PDF] [Request Permissions]

C. Christodoulou, D. Bafaloukos, P. Kosmidis, E. Samantas, A. Bamias, P. Papakostas, A. Karabelis, C. Bacoyiannis, and D. V. Skarlos

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
Ann Oncol 12: 249-254.
[Abstract] [PDF] [Request Permissions]

A. A. Brandes, M. Ermani, U. Basso, P. Amistà, F. Berti, R. Scienza, A. Rotilio, G. Pinna, M. Gardiman, and S. Monfardini

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
Ann Oncol 12: 255-257.
[Abstract] [PDF] [Request Permissions]

M. Brada, K. Hoang-Xuan, R. Rampling, P-Y. Dietrich, L. Y. Dirix, D. Macdonald, J. J. Heimans, B. A. Zonnenberg, J. M. Bravo-Marques, R. Henriksson, R. Stupp, N. Yue, J. Bruner, M. Dugan, S. Rao, and S. Zaknoen

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
Ann Oncol 12: 259-266.
[Abstract] [PDF] [Request Permissions]

Clinical case:

T. Cufer and M. Bracko

Myeloid metaplasia of the breast
Ann Oncol 12: 267-270.
[Abstract] [PDF] [Request Permissions]

N. Bangalore, P. Bhargava, M. J. Hawkins, and P. Bhargava

Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature
Ann Oncol 12: 271-274.
[Abstract] [PDF] [Request Permissions]

A. Fléchon, C. Lombard-Bohas, J. Boulez, J.-Y. Blay, and J.-Y. Scoazec

Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment
Ann Oncol 12: 275-276.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

P. Lippe, R. Berardi, L. Latini, R. Bracci, and R. Cellerino

Severe prognosis of signet-ring cell adenocarcinoma occurring in Meckel's diverticulum
Ann Oncol 12: 277.
[PDF] [Request Permissions]

R. P. Abratt

Representation on International Scientific Committees
Ann Oncol 12: 277-278.
[PDF] [Request Permissions]

D. G. Haller

Combination chemotherapy for colon cancer: De gustibus non est disputandum
Ann Oncol 12: 278.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.